Patent & IP news for January 30, 2017

Monday Miscellany from ipkitten.blogspot.com

The first issue of the Journal of Intellectual Property Law and Practice (JIPLP) of 2017 is available. This edition includes articles covering the German doctrine of free use, registrability of trademarks in Italy, online copyright ...

Share via E–mail | Twitter | Facebook

One Up Two Down: Trump Orders on Regulation from patentlyo.com

President Donald Trump’s newest executive order is the simplistic two-for-one regulatory that simple states: every time an agency “publicly proposes … or otherwise promulgates a new regulation, it shall identify at least two existing regulations ...

Share via E–mail | Twitter | Facebook

Webinar on Drafting for Alice from www.patentdocs.org

LexisNexis will be offering a webinar/teleconference entitled "Drafting for Alice in 2017: Trends and Best Practices" on January 31, 2017 at 2:00 pm (ET). Gene Quinn of IPWatchdog.com, Kate Gaudry of Kilpatrick ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from www.patentdocs.org

January 31, 2017 - "Patent Mistakes in the Administrative State" (John Marshall Law School Center for Intellectual Property, Information & Privacy Law) - 12:00 to 1:30 pm, Chicago, IL January 31, 2017 - "Proving and Avoiding Inequitable ...

Share via E–mail | Twitter | Facebook

IPO Webinar on Venue Tactics from www.patentdocs.org

The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Waiting for Heartland: Venue Tactics Until the U.S. Supreme Court Decision" on February 1, 2017 from 2:00 to 3:00 pm ...

Share via E–mail | Twitter | Facebook

In re Schweickert (Fed. Cir. 2017) from www.patentdocs.org

USPTO's Conclusion of Obviousness Rendered Primary Reference Unsatisfactory for Intended Purpose By Joseph Herndon -- In a nonprecedential opinion, the Federal Circuit vacated a decision by the Board and remanded the case on appeal from ...

Share via E–mail | Twitter | Facebook

WHO Board Agrees To Drop The Word ‘Counterfeit’ After 30 Years from www.ip-watch.org

For nearly 30 years, the United Nations World Health Organization has been referring to poor-quality and fake medicines as counterfeit. But that is about to change. The new words approved by the WHO Executive Board ...

Share via E–mail | Twitter | Facebook

Counsel Not Liable for Attorney Fees Award Under 35 U.S.C. § 285 from docketreport.blogspot.com

Following summary judgment of noninfringement, the court granted defendant's motion for attorney fees under 35 U.S.C. § 285, but denied defendant's motion to hold plaintiffs' counsel jointly and severally liable for those ...

Share via E–mail | Twitter | Facebook

WHO Members Negotiate Resolution On Cancer; High Prices In Question from www.ip-watch.org

Cancer is spreading. According to the World Health Organization, the number of new cases of cancer is projected to increase to 21.6 million annually by 2030. The WHO Executive Board this week is considering ...

Share via E–mail | Twitter | Facebook

NY Times opinion piece labels patent system a "relic of the feudal guild system" from ipbiz.blogspot.com

In a piece titled -- End Patent and Copyright Requirements in Nafta --, Dean Baker writes:


Drugs that would be readily available in a free market can be prohibitively expensive because of patent protection. For example, the ...

Share via E–mail | Twitter | Facebook

Video of Oral Argument of Ninth Circuit Copyright Case from www.717madisonplace.com

The Ninth Circuit decided a copyright case this month, Perfect 10, Inc. v. GIGANEWS, INC., No. 15-55500 (9th Cir. Jan. 23, 2017). The decision is available [here].   One of the issues was attorney’s fees ...

Share via E–mail | Twitter | Facebook

WTO Members Celebrate Treaty Amendment On Medicines Access, Look Ahead from www.ip-watch.org

A high-level meeting at the World Trade Organization today welcomed in an amendment to international trade rules for intellectual property aimed at boosting exports of affordable medicines. It also set out the way ahead to ...

Share via E–mail | Twitter | Facebook